1-4 of 4
raloxifene
Close
Sort by
Journal Articles

A Systematic Review On The Use Of Pharmacological Agents In Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Mansoor Radwi, MD, Arjuna Ponnampalam, MD, Marie E Faughnan, MD, Nadine Shehata, MD, MSC
Journal: Blood
Blood (2013) 122 (21): 4745.
https://doi.org/10.1182/blood.V122.21.4745.4745
Published: 2013
Journal Articles

Regulation of the Gene Encoding Human Thrombin-Activable Fibrinolysis Inhibitor by Female Sex Steroids

Mathieu Garand, M.Sc., Michael B Boffa, Ph.D., Marlys L. Koschinsky, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 3077.
https://doi.org/10.1182/blood.V112.11.3077.3077
Published: 2008
Journal Articles

Effect of Cyclosporine A and Estrogen-Receptor Inhibitor on the Reversion of Multidrug Resistance of K562/A02 Line.

Bao-An Chen, MD, PhD, Wen Bao, MD, Feng Gao, MD, Jian Cheng, MD, Chong Gao, MD, Jia-Hua Ding, MD, Yun-Yu Sun, MD, Jun Wang, MD, Gang Zhao, MD, Ning-Na Chen, MD, Fei Fei, MD
Journal: Blood
Blood (2006) 108 (11): 4358.
https://doi.org/10.1182/blood.V108.11.4358.4358
Published: 2006
Journal Articles

Production of Tissue Factor Pathway Inhibitor in Endothelial Cell Cultures Is Reduced by Estrogens, Selective Estrogen Receptor Modifiers, and a Selective Estrogen Receptor Downregulator.

Anders E.A. Dahm, MD, Nina Iversen, PhD, Baard Birkenes, Per Morten Sandset, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3961.
https://doi.org/10.1182/blood.V106.11.3961.3961
Published: 2005